{
    "medicine_id": "98d84b49ccc0199fc9aa4a59595cbba712041b7e",
    "platform_id": "DB01265",
    "metadata": {
        "name": "Sebivo 600 mg Tablet film coated",
        "composition": "600 mg Telbivudine",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of chronic hepatitis B in adult and adolescent patients 16 years of age with evidence of viral replication and either evidence of persistent elevations in serum aminotransferases ALT or AST or histologically active disease",
            "contraindications": {
                "disease": "There is no information on intentional overdose of telbivudine but one subject experienced an unintentional and asymptomatic overdose Healthy subjects who received telbivudine doses up to 1800 mg day for 4 days had no increase in or unexpected adverse events A maximum tolerated dose for telbivudine has not been determined",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Telbivudine is a synthetic thymidine nucleoside analogue with activity against hepatitis B virus HBV Telbivudine is the unmodified \u03b2 L enantiomer of the naturally occurring nucleoside thymidine It undergoes phosphorylation via interaction with cellular kinases to form the active metabolite telbivudine 5 triphosphate",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00008",
                        "description": "The risk or severity of adverse effects can be increased when Peginterferon alfa 2a is combined with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The risk or severity of adverse effects can be increased when Peginterferon alfa 2b is combined with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB00811",
                        "description": "Ribavirin may increase the hepatotoxic activities of Telbivudine"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa n3 is combined with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa 2a Recombinant is combined with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfacon 1 is combined with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa 2b is combined with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "The risk or severity of cytopenia can be increased when Ganciclovir is combined with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB01610",
                        "description": "The risk or severity of cytopenia can be increased when Valganciclovir is combined with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB10317",
                        "description": "The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB10343",
                        "description": "The therapeutic efficacy of Bacillus calmette guerin substrain tice live antigen can be decreased when used in combination with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB10804",
                        "description": "The therapeutic efficacy of Bacillus calmette guerin substrain connaught live antigen can be decreased when used in combination with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB10805",
                        "description": "The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB11003",
                        "description": "The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB11050",
                        "description": "The therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB12386",
                        "description": "The therapeutic efficacy of Bacillus calmette guerin substrain danish 1331 live antigen can be decreased when used in combination with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB14409",
                        "description": "The therapeutic efficacy of Human adenovirus e serotype 4 strain cl 68578 antigen can be decreased when used in combination with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The therapeutic efficacy of Vibrio cholerae CVD 103 HgR strain live antigen can be decreased when used in combination with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB14685",
                        "description": "The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Telbivudine"
                    },
                    {
                        "drugbank-id": "DB10318",
                        "description": "The therapeutic efficacy of Varicella Zoster Vaccine Live attenuated can be decreased when used in combination with Telbivudine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}